IT1312088B1 - Cerotto per uso topico contenente eparina e diclofenac. - Google Patents

Cerotto per uso topico contenente eparina e diclofenac.

Info

Publication number
IT1312088B1
IT1312088B1 IT1999MI000834A ITMI990834A IT1312088B1 IT 1312088 B1 IT1312088 B1 IT 1312088B1 IT 1999MI000834 A IT1999MI000834 A IT 1999MI000834A IT MI990834 A ITMI990834 A IT MI990834A IT 1312088 B1 IT1312088 B1 IT 1312088B1
Authority
IT
Italy
Prior art keywords
topical use
diclofenac
patch
use containing
containing heparin
Prior art date
Application number
IT1999MI000834A
Other languages
English (en)
Inventor
Elisabetta Donati
Irina Rapaport
Original Assignee
Altergon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT1999MI000834A priority Critical patent/IT1312088B1/it
Application filed by Altergon Sa filed Critical Altergon Sa
Priority to PT00107835T priority patent/PT1046395E/pt
Priority to DK00107835T priority patent/DK1046395T3/da
Priority to EP00107835A priority patent/EP1046395B1/en
Priority to AT00107835T priority patent/ATE297717T1/de
Priority to ES00107835T priority patent/ES2244373T3/es
Priority to DE60020768T priority patent/DE60020768T2/de
Priority to US09/549,254 priority patent/US6592891B1/en
Priority to CA002306214A priority patent/CA2306214C/en
Publication of ITMI990834A1 publication Critical patent/ITMI990834A1/it
Application granted granted Critical
Publication of IT1312088B1 publication Critical patent/IT1312088B1/it
Priority to US10/448,492 priority patent/US20030203017A1/en
Priority to US10/957,031 priority patent/US7799338B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT1999MI000834A 1999-04-21 1999-04-21 Cerotto per uso topico contenente eparina e diclofenac. IT1312088B1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT1999MI000834A IT1312088B1 (it) 1999-04-21 1999-04-21 Cerotto per uso topico contenente eparina e diclofenac.
DK00107835T DK1046395T3 (da) 1999-04-21 2000-04-12 Plaster indeholdende heparin og diclofenac til topisk anvendelse
EP00107835A EP1046395B1 (en) 1999-04-21 2000-04-12 Plaster for topical use containing heparin and diclofenac
AT00107835T ATE297717T1 (de) 1999-04-21 2000-04-12 Heparin und diclofenac enthaltendes topisches pflaster
PT00107835T PT1046395E (pt) 1999-04-21 2000-04-12 Emplastro para utilizacao topica contendo heparina e diclofenac
ES00107835T ES2244373T3 (es) 1999-04-21 2000-04-12 Emplasto de uso topico que contiene heparina y diclofenaco.
DE60020768T DE60020768T2 (de) 1999-04-21 2000-04-12 Heparin und Diclofenac enthaltendes topisches Pflaster
US09/549,254 US6592891B1 (en) 1999-04-21 2000-04-14 Plaster for topical use containing heparin and diclofenac
CA002306214A CA2306214C (en) 1999-04-21 2000-04-19 Plaster for topical use containing heparin and diclofenac
US10/448,492 US20030203017A1 (en) 1999-04-21 2003-05-29 Plaster for topical use containing heparin and diclofenac
US10/957,031 US7799338B2 (en) 1999-04-21 2004-10-04 Plaster for topical use containing heparin and diclofenac

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI000834A IT1312088B1 (it) 1999-04-21 1999-04-21 Cerotto per uso topico contenente eparina e diclofenac.

Publications (2)

Publication Number Publication Date
ITMI990834A1 ITMI990834A1 (it) 2000-10-21
IT1312088B1 true IT1312088B1 (it) 2002-04-04

Family

ID=11382783

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI000834A IT1312088B1 (it) 1999-04-21 1999-04-21 Cerotto per uso topico contenente eparina e diclofenac.

Country Status (9)

Country Link
US (3) US6592891B1 (it)
EP (1) EP1046395B1 (it)
AT (1) ATE297717T1 (it)
CA (1) CA2306214C (it)
DE (1) DE60020768T2 (it)
DK (1) DK1046395T3 (it)
ES (1) ES2244373T3 (it)
IT (1) IT1312088B1 (it)
PT (1) PT1046395E (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0215068A (pt) 2001-12-21 2004-11-09 Coloplast As Dispositivo para cuidar de feridas
TW200427470A (en) * 2002-10-30 2004-12-16 Showa Denko Kk Adhesive composition for dermal patch and production process thereof
JP2004168764A (ja) * 2002-10-30 2004-06-17 Showa Denko Kk 貼付剤用粘着剤組成物およびその製造方法
WO2005055945A2 (en) * 2003-12-08 2005-06-23 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
WO2006025583A1 (ja) * 2004-08-31 2006-03-09 Aspion Co., Ltd. Ｓ／ｏ型外用剤
WO2006112533A1 (en) * 2005-04-18 2006-10-26 Showa Denko K.K. Water-containing gel form and production method thereof
US20100323323A1 (en) * 2005-06-24 2010-12-23 Cao Group, Inc. Pliable gingival isolation material
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
ES2472545T3 (es) 2006-07-25 2014-07-01 Techfields Biochem Co. Ltd Profármacos de diclofenaco solubles en agua con carga positiva y con una tasa de penetración en piel muy rápida
RU2509076C2 (ru) 2007-06-04 2014-03-10 Текфилдз Инк Пролекарства нестероидных противовоспалительных средств (nsaia) c очень высокой скоростью проникновения через кожу и мембраны и новые медицинские применения указанных пролекарств
CN104173321B (zh) * 2008-03-03 2017-10-31 阿尔特根有限公司 制备通过外用贴剂给药的、具有消炎镇痛活性的药物组合物的方法，及以此获得的组合物
CN101969936A (zh) * 2008-03-03 2011-02-09 阿尔特根有限公司 一种制备通过外用贴剂给药的、具有消炎镇痛活性的药物组合物的方法,以及用该方法所获得的组合物
US7943668B2 (en) 2008-03-03 2011-05-17 Altergon S.A. Process for preparing a pharmaceutical composition with anti-inflammatory and analgesic activity for administration via a patch for external use, and composition thus obtained
RU2765463C2 (ru) 2008-12-04 2022-01-31 Чунси ЮЙ Композиции интенсивного проникновения и их применение
CN103357059B (zh) * 2012-03-27 2016-08-03 上海卫生材料厂有限公司 几丁质凝胶创可贴
US10905669B2 (en) 2015-02-20 2021-02-02 Altergon S.A. Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug
EP3173066A1 (en) * 2015-11-25 2017-05-31 Krzysztof Kubica Plaster comprising antiedematous substances for the treatment of bruising and injury

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855142A (en) * 1987-02-27 1989-08-08 Ciba-Geigy Corporation Pharmaceutical plaster
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
US5041430A (en) * 1989-09-18 1991-08-20 Du Pont Mereck Pharmaceutical Company Oral anticoagulant/platelet inhibitor low dose formulation
US5217954A (en) * 1990-04-04 1993-06-08 Scios Nova Inc. Formulations for stabilizing fibroblast growth factor
JP2849937B2 (ja) * 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
US5260066A (en) * 1992-01-16 1993-11-09 Srchem Incorporated Cryogel bandage containing therapeutic agent
IL101387A (en) * 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
JP3526887B2 (ja) * 1993-04-23 2004-05-17 帝國製薬株式会社 消炎鎮痛外用貼付剤
US5668119A (en) * 1996-02-22 1997-09-16 Medenica; Rajko D. Topical pharmaceutical containing heparin and method of treatment
WO1997042944A1 (en) * 1996-05-13 1997-11-20 Novartis Consumer Health S.A. Topical composition
GB2320431B (en) * 1996-12-20 2000-08-30 Johnson & Johnson Medical Compositions for the treatment of chronic wounds

Also Published As

Publication number Publication date
US20030203017A1 (en) 2003-10-30
US20050048101A1 (en) 2005-03-03
DK1046395T3 (da) 2005-10-03
ATE297717T1 (de) 2005-07-15
PT1046395E (pt) 2005-10-31
EP1046395B1 (en) 2005-06-15
DE60020768D1 (de) 2005-07-21
ITMI990834A1 (it) 2000-10-21
CA2306214A1 (en) 2000-10-21
DE60020768T2 (de) 2006-05-18
CA2306214C (en) 2009-10-20
US7799338B2 (en) 2010-09-21
ES2244373T3 (es) 2005-12-16
EP1046395A1 (en) 2000-10-25
US6592891B1 (en) 2003-07-15

Similar Documents

Publication Publication Date Title
IT1312088B1 (it) Cerotto per uso topico contenente eparina e diclofenac.
ES2581574T3 (es) Sistema terapéutico transdérmico para la administración del principio activo buprenorfina
WO2004103415A3 (en) Multi-dressing system for managing skin wounds
HUP0103715A2 (hu) Topikus tapasz savcsoportot tartalmazó nemszteroid reumaellenes hatóanyaggal
DK0973497T3 (da) Farmaceutisk bæreanordning, egnet til udlevering af farmaceutiske forbindelser til slimhindeoverflade
DK1009393T3 (da) Transdermalt, terapeutisk system med hæfteklæbende reservoirlag og bagsidelag, som er elastisk i én retning
DE602005016185D1 (de) Druckempfindliche Klebstoffzusammensetzung, druckempfindliches Klebeband und Oberflächenschutzfilm
JP2005512112A5 (it)
NO20050472L (no) Forbedret transdermalt leveringssystem for administrering av rotigotin
JP2005502430A5 (it)
WO2003018075A3 (de) Transdermales therapeutisches system mit fentanyl bzw. verwandten substanzen
HK1108350A1 (en) Cooling topical patch preparation
TW200501939A (en) Patch containing nonsteroidal anti-inflammatory and analgesic agent
WO2005021042A8 (ja) 活性エネルギー線硬化型皮膚貼付剤用組成物及び皮膚貼付剤
DK1355636T3 (da) Transdermalt terapeutisk system til administrering af carboxylgruppeholdige, ikke-steroidale antiflogistika samt en fremgangsmåde til fremstilling deraf
AU2003230032A1 (en) Transdermal delivery system with two superimposed adhesive layers having different affinities to the active substance comprised
AU2003234936A1 (en) Liquid crystal aligning agent, liquid crystal aligning films and liquid crystal display devices
CA2387143A1 (en) Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin
ATE209912T1 (de) Transdermales therapeutisches system (tts) oxybutynin enthaltend
WO2003066130A3 (en) Transdermal drug delivery systems
DE50111208D1 (de) Matrixkontrolliertes transdermales system für stabile derivate der ace-hemmer
EP1034780A3 (en) Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis, dermatitis and dermatosis
HUP0204448A2 (en) Trnasdermal therapeutic system for the delivery of lerisetron
WO2002022109A3 (en) Patch comprising diclofenac
AU2002210132A1 (en) Occlusive transdermal therapeutic system with a non-occlusive backing layer